First results are given from the comparison of experimental values and model calculations on accelerator-produced high specific activity radionuclides in no-carrier-added (NCA) form. The relevant radioisotopes are : Cu-64, produced by Zn-nat(d, alphaxn) and Zn-nat(d,2p) reactions, for simultaneous positron/negatron metabolic radiotherapy and PET imaging; Ga-66 high-energy positron emitter (4.2 MeV), produced by Zn-nat(d,xn) reactions, for metabolic radiotherapy and for PET: Re-186g, produced by W-186(p,n) and W-186(d,2n) reactions, for negatron (1.1 MeV) metabolic radiotherapy; At-211/Po-211, produced by Bi-209(alpha,2n) reaction (with spike of gamma emitter At-210 produced by Bi-209(alpha,3n) reaction) and Ac-225/Bi-213/Po-213 produced by Ra-226(p,2n) reaction, both for high-LET radiotherapy.
Experimental results and model calculations of excitation functions relevant to the production of specific radioisotopes for metabolic radiotherapy and for PET / E. Menapace, C. Birattari, M.L. Bonardi, F. Groppi. - In: RADIATION PHYSICS AND CHEMISTRY. - ISSN 0969-806X. - 71:3-4(2004), pp. 943-945.
Experimental results and model calculations of excitation functions relevant to the production of specific radioisotopes for metabolic radiotherapy and for PET
C. BirattariSecondo
;M.L. BonardiPenultimo
;F. GroppiUltimo
2004
Abstract
First results are given from the comparison of experimental values and model calculations on accelerator-produced high specific activity radionuclides in no-carrier-added (NCA) form. The relevant radioisotopes are : Cu-64, produced by Zn-nat(d, alphaxn) and Zn-nat(d,2p) reactions, for simultaneous positron/negatron metabolic radiotherapy and PET imaging; Ga-66 high-energy positron emitter (4.2 MeV), produced by Zn-nat(d,xn) reactions, for metabolic radiotherapy and for PET: Re-186g, produced by W-186(p,n) and W-186(d,2n) reactions, for negatron (1.1 MeV) metabolic radiotherapy; At-211/Po-211, produced by Bi-209(alpha,2n) reaction (with spike of gamma emitter At-210 produced by Bi-209(alpha,3n) reaction) and Ac-225/Bi-213/Po-213 produced by Ra-226(p,2n) reaction, both for high-LET radiotherapy.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.